Literature DB >> 21460035

The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity.

Ferdinand Kappes1, Tanja Waldmann, Veena Mathew, Jindan Yu, Ling Zhang, Michael S Khodadoust, Arul M Chinnaiyan, Karolin Luger, Sylvia Erhardt, Robert Schneider, David M Markovitz.   

Abstract

Heterochromatin integrity is crucial for genome stability and regulation of gene expression, but the factors involved in mammalian heterochromatin biology are only incompletely understood. Here we identify the oncoprotein DEK, an abundant nuclear protein with a previously enigmatic in vivo function, as a Suppressor of Variegation [Su(var)] that is crucial to global heterochromatin integrity. We show that DEK interacts directly with Heterochromatin Protein 1 α (HP1α) and markedly enhances its binding to trimethylated H3K9 (H3K9me3), which is key for maintaining heterochromatic regions. Loss of Dek in Drosophila leads to a Su(var) phenotype and global reduction in heterochromatin. Thus, these findings show that DEK is a key factor in maintaining the balance between heterochromatin and euchromatin in vivo.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21460035      PMCID: PMC3070930          DOI: 10.1101/gad.2036411

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  32 in total

1.  Subcellular localization of the human proto-oncogene protein DEK.

Authors:  F Kappes; K Burger; M Baack; F O Fackelmayer; C Gruss
Journal:  J Biol Chem       Date:  2001-05-01       Impact factor: 5.157

Review 2.  Control of tumorigenesis and chemoresistance by the DEK oncogene.

Authors:  Erica Riveiro-Falkenbach; María S Soengas
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

3.  DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.

Authors:  Nirit Mor-Vaknin; Ferdinand Kappes; Amalie E Dick; Maureen Legendre; Catalina Damoc; Seagal Teitz-Tennenbaum; Roland Kwok; Elisa Ferrando-May; Barbara S Adams; David M Markovitz
Journal:  Arthritis Rheum       Date:  2011-02

4.  Protein phosphatase 2A activates the HIV-2 promoter through enhancer elements that include the pets site.

Authors:  N E Faulkner; J M Hilfinger; D M Markovitz
Journal:  J Biol Chem       Date:  2001-04-24       Impact factor: 5.157

5.  Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.

Authors:  A J Bannister; P Zegerman; J F Partridge; E A Miska; J O Thomas; R C Allshire; T Kouzarides
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

6.  Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.

Authors:  M Lachner; D O'Carroll; S Rea; K Mechtler; T Jenuwein
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

7.  DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.

Authors:  F Kappes; J Fahrer; M S Khodadoust; A Tabbert; C Strasser; N Mor-Vaknin; M Moreno-Villanueva; A Bürkle; D M Markovitz; E Ferrando-May
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

8.  DEK proto-oncogene expression interferes with the normal epithelial differentiation program.

Authors:  Trisha M Wise-Draper; Richard J Morreale; Teresa A Morris; Rachael A Mintz-Cole; Elizabeth E Hoskins; Scott J Balsitis; Nader Husseinzadeh; David P Witte; Kathryn A Wikenheiser-Brokamp; Paul F Lambert; Susanne I Wells
Journal:  Am J Pathol       Date:  2008-11-26       Impact factor: 4.307

9.  Melanoma proliferation and chemoresistance controlled by the DEK oncogene.

Authors:  Michael S Khodadoust; Monique Verhaegen; Ferdinand Kappes; Erica Riveiro-Falkenbach; Juan C Cigudosa; David S L Kim; Arul M Chinnaiyan; David M Markovitz; María S Soengas
Journal:  Cancer Res       Date:  2009-08-15       Impact factor: 12.701

10.  A histone chaperone, DEK, transcriptionally coactivates a nuclear receptor.

Authors:  Shun Sawatsubashi; Takuya Murata; Jinseon Lim; Ryoji Fujiki; Saya Ito; Eriko Suzuki; Masahiko Tanabe; Yue Zhao; Shuhei Kimura; Sally Fujiyama; Takashi Ueda; Daiki Umetsu; Takashi Ito; Ken-ichi Takeyama; Shigeaki Kato
Journal:  Genes Dev       Date:  2009-12-29       Impact factor: 11.361

View more
  44 in total

1.  Hepatic ontogeny and tissue distribution of mRNAs of epigenetic modifiers in mice using RNA-sequencing.

Authors:  Hong Lu; Julia Yue Cui; Sumedha Gunewardena; Byunggil Yoo; Xiao-bo Zhong; Curtis D Klaassen
Journal:  Epigenetics       Date:  2012-07-09       Impact factor: 4.528

2.  The nuclear DEK interactome supports multi-functionality.

Authors:  Eric A Smith; Eric F Krumpelbeck; Anil G Jegga; Malte Prell; Marie M Matrka; Ferdinand Kappes; Kenneth D Greis; Abdullah M Ali; Amom R Meetei; Susanne I Wells
Journal:  Proteins       Date:  2017-11-11

3.  Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.

Authors:  Maegan L Capitano; Nirit Mor-Vaknin; Anjan K Saha; Scott Cooper; Maureen Legendre; Haihong Guo; Rafael Contreras-Galindo; Ferdinand Kappes; Maureen A Sartor; Christopher T Lee; Xinxin Huang; David M Markovitz; Hal E Broxmeyer
Journal:  J Clin Invest       Date:  2019-05-20       Impact factor: 14.808

Review 4.  The DEK oncoprotein and its emerging roles in gene regulation.

Authors:  C Sandén; U Gullberg
Journal:  Leukemia       Date:  2015-03-13       Impact factor: 11.528

5.  All hands on DEK.

Authors:  David M Bodine
Journal:  J Clin Invest       Date:  2019-05-20       Impact factor: 14.808

6.  Intercellular trafficking of the nuclear oncoprotein DEK.

Authors:  Anjan K Saha; Ferdinand Kappes; Amruta Mundade; Anja Deutzmann; David M Rosmarin; Maureen Legendre; Nicolas Chatain; Zeina Al-Obaidi; Barbara S Adams; Hidde L Ploegh; Elisa Ferrando-May; Nirit Mor-Vaknin; David M Markovitz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

7.  DEK regulates hematopoietic stem engraftment and progenitor cell proliferation.

Authors:  Hal E Broxmeyer; Ferdinand Kappes; Nirit Mor-Vaknin; Maureen Legendre; John Kinzfogl; Scott Cooper; Giao Hangoc; David M Markovitz
Journal:  Stem Cells Dev       Date:  2011-10-27       Impact factor: 3.272

8.  The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress.

Authors:  A Deutzmann; M Ganz; F Schönenberger; J Vervoorts; F Kappes; E Ferrando-May
Journal:  Oncogene       Date:  2014-10-27       Impact factor: 9.867

Review 9.  Stacking the DEK: from chromatin topology to cancer stem cells.

Authors:  Lisa M Privette Vinnedge; Ferdinand Kappes; Nicolas Nassar; Susanne I Wells
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

Review 10.  Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function.

Authors:  Hal E Broxmeyer
Journal:  Ann N Y Acad Sci       Date:  2012-08       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.